The reiteration of a Hold rating by a prominent analyst suggests that there are no significant short-term changes expected in Sage Therapeutics' stock performance. This rating indicates a neutral view on the stock, implying that the analyst does not foresee any immediate positive or negative developments that could significantly impact the stock price.